Eledon Pharmaceuticals Inc. Common Stock (ELDN)
Stock · NASDAQ · Health Care
$3.2as of 8/28/2026
Price chart
Open in TradingViewActive signals
Resistance level
$3.42
Industry
Biotechnology: Pharmaceutical Preparations
About ELDN
Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biologi…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 33
- Website
- eledon.com/
Fundamentals
- 1-day range
- $3.17$3.32
- Market cap
- $264.75M
- P/E (trailing)
- —
- P/E (forward)
- -4.16
- EPS (trailing)
- $-0.83
- Dividend yield
- —
- Beta
- 0.87
- Avg. volume
- 1.27M
- Dividend pay date
- October 5, 2020
52-week range
$1.35$4.6
Next earnings: November 13, 2026 · EPS estimate $-0.19confirmed
Forecasts
5 analyst ratings
Buy 92%
Hold 8%
Sell 0%
1-year price forecast
High
$12
+275.0%
Median
$8
+150.0%
Low
$7
+118.7%
Eledon Pharmaceuticals Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ELDNEledon Pharmaceuticals Inc. Common Stock$3.19▼ 3.92%Market cap $264.75MP/E —$1.35$4.6
- IMRXImmuneering Corporation Class A Common Stock$4.99▼ 4.22%Market cap $269.79MP/E —$3.86$10.08
- ALXOALX Oncology Holdings Inc. Common Stock$2▼ 2.44%Market cap $259.71MP/E —$0.96$2.66
- VRXAVeraxa Biotech AG Ordinary Shares$1.36▼ 5.56%Market cap $258.78MP/E —$1.32$27.36
- BCYCBicycle Therapeutics plc American Depositary Shares$4.21▼ 2.77%Market cap $270.87MP/E —$3.75$9.16
- FULCFulcrum Therapeutics Inc. Common Stock$3.85▲ 0.00%Market cap $283.06MP/E —$2.83$15.74
- MGNXMacroGenics Inc. Common Stock$4.13▲ 1.23%Market cap $242.81MP/E —$1.29$5.08
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ELDN Eledon Pharmaceuticals Inc. Common Stock | $264.75M | — | $3.19 | ▼ 3.92% | $1.35$4.6 |
| IMRX Immuneering Corporation Class A Common Stock | $269.79M | — | $4.99 | ▼ 4.22% | $3.86$10.08 |
| ALXO ALX Oncology Holdings Inc. Common Stock | $259.71M | — | $2 | ▼ 2.44% | $0.96$2.66 |
| VRXA Veraxa Biotech AG Ordinary Shares | $258.78M | — | $1.36 | ▼ 5.56% | $1.32$27.36 |
| BCYC Bicycle Therapeutics plc American Depositary Shares | $270.87M | — | $4.21 | ▼ 2.77% | $3.75$9.16 |
| FULC Fulcrum Therapeutics Inc. Common Stock | $283.06M | — | $3.85 | ▲ 0.00% | $2.83$15.74 |
| MGNX MacroGenics Inc. Common Stock | $242.81M | — | $4.13 | ▲ 1.23% | $1.29$5.08 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Eledon Pharma Q2 EPS $(0.27) Misses $(0.16) Estimatebenzinga · 8/13/2026
- Eledon Pharma Q2 EPS $(0.27) Misses $(0.16) EstimateBenzinga · 8/13/2026
Insider Activity
Insider Actions →Acquired
506.8K
Disposed
266.9K
- David-Alexandre C. Gros · July 31, 2026 · Tax Withholding194.8K @ $3.38
- David-Alexandre C. Gros · July 31, 2026 · Grant354.5K
- Steven Perrin · July 31, 2026 · Tax Withholding72.1K @ $3.38
- Steven Perrin · July 31, 2026 · Grant152.4K
Institutional Ownership
March 31, 2026
- Total shares held
- 41.73M
- Total value held
- $126.07M
- Institutional holders
- 119
Top holders this quarter
- Unknown6.29M
- Unknown4.38M
- Unknown3.56M
- Unknown3.29M
- Unknown2.46M
- Unknown1.88M
- Unknown1.79M
- Unknown1.77M
- Unknown1.64M
- Unknown1.42M
See the full, filterable feed with live charts on the MarketWall dashboard.